Good to here from you again! I thought maybe you were hiding for some reason. Let us take a quick review of where all stands here.
On the negative side, a financing in say 5-12 months is certainly possible if they are not able to garner any partnership bucks in time. That would get you back to about even on the $4.70 short.
On the positive side:
. 5 pivital trials (1 launched, 4 soon) ALL paid for with partner cash.
. 4 mid stage candidates, all suitable for partnering and 2 potentially advanced on their own.
. Up to $3Billion of potential milestones on partnered drugs (w/o help from those above 4 mentioned compunds).
. Various scattered programs that we can ignore.
Given that picture, one would have thought most shorts would have used yesterdays dip to cover wioth a mild loss and be glad to escape with the scalp attached.
BTW, noticed you changed from "it will be under $3 soon", to $4 soon, now $5. Can't wait for 6,7...
I was glad to be stopped out too. This was promoted heavily by a certain group that I follow, when they folded, this went down almost 20% in a day. I got out and not coming back. Thei technology is fine, but doen not guarantee a drug. The problem is that it will take a lot of money to continue and they don't have it. I am sure that the same Company that took ARRY up is the same ones to short it down. That is how they play. This thing will fall for a while. ASCO could not save it.
Look: they've been burning thru cash since forever....just because earnings came out worse than expected is NOT /should NOT have been a surprise......this is NOT an earnings play...!!!! The question is, will their drugs in phases 2/3 eventually make it to market...?!??? if so, this should be another JAZZ, as everyone has been saying...nothing should have changed since last Monday....